Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

416

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Advanced Solid Tumor
Interventions
DRUG

Denikitug

Administered Intravenously

DRUG

Zimberelimab

Administered Intravenously

Trial Locations (26)

100

RECRUITING

National Taiwan University Hospital, Taipei

110

WITHDRAWN

Taipei Tzu Chi General Hospital, Taipei

500

RECRUITING

Changhua Christian Hospital, Changhua

2050

RECRUITING

Chris O'Brien Lifehouse, Camperdown

3000

RECRUITING

Peter MacCallum Cancer Centre, Melbourne

3168

RECRUITING

Monash Medical Centre, Clayton

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

28033

RECRUITING

MD Anderson Cancer Center, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28223

RECRUITING

Hospital Universitario Quironsalud Madrid, Madrid

31008

RECRUITING

Clinica Universidad de Navarra, Pamplona

33308

RECRUITING

Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital, Taoyuan

37203

RECRUITING

Tennessee Oncology, PLLC, Nashville

39090

RECRUITING

University of Texas Southwestern Medical Center, Dallas

53705

RECRUITING

University of Wisconsin Clinical Sciences Center, Madison

73657

RECRUITING

Chi Mei Hospital, Liouying, Tainan City

75230

RECRUITING

Mary Crowley Cancer Research, Dallas

77030

RECRUITING

MD Anderson Cancer Center, Houston

78229

RECRUITING

NEXT Oncology, San Antonio

92093

RECRUITING

University of California San Diego, La Jolla

94305

RECRUITING

Stanford Cancer Center, Palo Alto

100229

RECRUITING

National Taiwan University Cancer Center (NTUCC), Taipei

06510

COMPLETED

Smilow Cancer Center, New Haven

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

M5G 2M9

RECRUITING

University Health Network, Princess Margaret Cancer Centre, Toronto

08035

RECRUITING

Hospital Universitari Vall d´Hebrón, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY